Cytokinetics
CYTK
CYTK
345 hedge funds and large institutions have $7.2B invested in Cytokinetics in 2024 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 147 increasing their positions, 94 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2% less capital invested
Capital invested by funds: $7.34B → $7.2B (-$141M)
2.43% less ownership
Funds ownership: 118.21% → 115.78% (-2.4%)
25% less funds holding in top 10
Funds holding in top 10: 20 → 15 (-5)
Holders
345
Holding in Top 10
15
Calls
$278M
Puts
$154M
Top Buyers
| 1 | +$81.9M | |
| 2 | +$42.6M | |
| 3 | +$30.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$30.2M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$26.3M |
Top Sellers
| 1 | -$246M | |
| 2 | -$30.4M | |
| 3 | -$28.6M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$26.8M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$25.5M |